M. Gantz
Member of Board
Diagnostic Division
Swedish Orphan Biovitrum
Ireland
Biography
Born 1965. BA Princeton University and MBA from Harvard Business School. Board member since 2012. Other appointments: Executive Vice President of BTG, an international specialist healthcare company. Previous appointments: Founder and previously CEO of Acureon Pharmaceuticals, President and CEO of Hydrabiosciences Inc., VP Europe for Chiron's Biopharmaceutical Division and General Manager for PathoGenesis Europe. Prior to Chiron/PathoGenesis a variety of US sales and marketing roles at Abbott Laboratories Diagnostic Division.
Research Interest
Expert in logistic and managing the board with his management skills in the pharmaceutical industries.
